FREDIANI, BRUNO
 Distribuzione geografica
Continente #
EU - Europa 15.804
NA - Nord America 15.704
AS - Asia 2.013
OC - Oceania 28
SA - Sud America 28
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 16
Totale 33.614
Nazione #
US - Stati Uniti d'America 15.665
GB - Regno Unito 5.265
IE - Irlanda 2.891
IT - Italia 2.280
CN - Cina 1.406
SE - Svezia 1.374
UA - Ucraina 1.266
DE - Germania 876
FR - Francia 851
FI - Finlandia 452
SG - Singapore 184
RU - Federazione Russa 161
VN - Vietnam 115
ES - Italia 92
CZ - Repubblica Ceca 91
IN - India 79
TR - Turchia 61
BE - Belgio 42
CA - Canada 35
IR - Iran 32
NL - Olanda 25
PK - Pakistan 24
AU - Australia 23
HK - Hong Kong 23
JP - Giappone 20
PL - Polonia 20
RO - Romania 20
GR - Grecia 18
EU - Europa 15
ID - Indonesia 14
AT - Austria 13
BR - Brasile 12
PT - Portogallo 10
CL - Cile 9
DK - Danimarca 7
EE - Estonia 7
MA - Marocco 7
SK - Slovacchia (Repubblica Slovacca) 7
BG - Bulgaria 6
CH - Svizzera 6
MK - Macedonia 6
PH - Filippine 6
AM - Armenia 5
IL - Israele 5
NZ - Nuova Zelanda 5
BD - Bangladesh 4
CY - Cipro 4
LT - Lituania 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
DZ - Algeria 3
EG - Egitto 3
HU - Ungheria 3
KR - Corea 3
LV - Lettonia 3
AZ - Azerbaigian 2
EC - Ecuador 2
ET - Etiopia 2
IM - Isola di Man 2
IQ - Iraq 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
PE - Perù 2
QA - Qatar 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MM - Myanmar 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
RS - Serbia 1
SL - Sierra Leone 1
TH - Thailandia 1
TM - Turkmenistan 1
Totale 33.614
Città #
Southend 4.898
Dublin 2.845
Fairfield 2.337
Ashburn 1.441
Chandler 1.384
Woodbridge 1.197
Jacksonville 986
Wilmington 943
Seattle 826
Houston 824
Cambridge 797
Menlo Park 720
Ann Arbor 651
Siena 541
Princeton 461
Nanjing 315
Beijing 286
Helsinki 266
New York 238
San Mateo 198
Boardman 191
San Diego 151
Florence 135
Dearborn 130
Milan 119
Moscow 115
Dong Ket 114
Nanchang 110
Singapore 103
Shanghai 101
Rome 91
Shenyang 79
Málaga 77
Lancaster 74
Hebei 63
Düsseldorf 59
London 57
Washington 55
Jiaxing 54
Tianjin 53
Fremont 52
Izmir 50
Olomouc 48
Norwalk 43
Guangzhou 42
Jinan 40
Kunming 40
Changsha 39
Brussels 38
Brno 37
Falls Church 37
Chicago 32
San Francisco 31
Mestre 29
Redwood City 27
Los Angeles 25
Zhengzhou 25
Taizhou 22
Hangzhou 21
Bologna 20
Toronto 20
Munich 19
Turin 19
Venezia 19
Livorno 18
Ningbo 18
Catania 17
Naples 17
Zanjan 17
Bergamo 14
Frankfurt am Main 14
Tappahannock 14
Vienna 14
Amsterdam 12
Bangalore 12
Hong Kong 12
Hyderabad 12
Padova 12
Venice 12
Verona 12
Aachen 11
Chianciano Terme 11
Greifswald 11
Hounslow 11
Uzzano 11
Comun Nuovo 10
Lappeenranta 10
Brescia 9
Carrara 9
Changchun 9
Kraków 9
Monza 9
Perugia 9
Pisa 9
Prescot 9
Salerno 9
Sutri 9
Asciano 8
Edinburgh 8
Hefei 8
Totale 25.276
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 345
Histological and Ultrastructural Characterization of Alkaptonuric Tissues 263
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 249
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 240
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients 238
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 225
A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria 224
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. 207
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 200
Radiologists and rheumatologists on performing and reporting shoulder ultrasound: From disagreement to consensus 195
Long-term effects of neridronate on human osteoblastic cell cultures 194
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 193
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 193
Bone mineral density in patients with systemic sclerosis. 191
Spasmophilia and entrapment nerve syndrome comorbidities in fibromyalgic patients: a possible neuromuscular pain generator. 191
Ultrasonography and magnetic resonance imaging of heel fat pad inflammatory-oedematous lesions in rheumatoid arthritis 189
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 189
Sonographic and electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. 188
Weekly oral alendronate in mevalonate kinase deficiency 187
Change perspective to increase diagnostic accuracy of ultrasonography in calcium pyrophosphate dehydrate deposition disease! A new approach: The axial scan of the meniscus 186
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 182
Antirheumatic agents in covid-19: is IL-6 the right target? 182
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 180
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 180
Cytoskeleton Aberrations in Alkaptonuric Chondrocytes 179
Peripheral biomarkers' panel for severe COVID-19 patients 179
FRI0501 Ultrasound versus synovial fluid analysis for the diagnosis of calcium pyrophosphate dihydrate deposition disease: preliminary results 178
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 177
SAT0312 Ultrasound Reliability in the Diagnosis of Calcium Pyrophosphate Deposition Disease: Agreement Between Observers and Main Causes of Discordance 177
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 177
Deltoideal acromial enthesopathy in ankylosing spondylitis and in spondylarthropathies: comment on the article by Lambert et al. 176
Genetic mechanisms of critical illness in COVID-19 175
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 174
Extracorporeal shock wave therapy in the treatment of inferior calcaneal enthesophytosis: outcome by fan-beam dual x ray absorptiometry (DXA). 173
Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound 173
A "new" technique for the diagnosis of chondrocalcinosis of the knee: sensitivity and specificity of high-frequency ultrasonography 172
Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress 171
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 171
null 171
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 168
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 167
Extent and distribution of CPP deposits in patients affected by calcium pyrophosphate dihydrate deposition disease: An ultrasonographic study 167
Angiogenesis in alkaptonuria 166
Working the endless puzzle of hereditary autoinflammatory disorders. 165
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 165
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 165
FRI0533 Ultrasonographic Features of Joints and Entheses in Healty Children 164
AB1308 Prevalence of baker’s CYST in patients with chronic gonalgia and relationship with major non inflammatory diseases 163
SAT0542 The Prevalence of Calcium Pyrophosphate Deposits at Ultrasound Examination: Retrospective Analysis in A Cohort of Patients 162
FRI0517 The Omeract Ultrasonographic Criteria for Elementary Lesions in Calcium Pyrophosphate Deposition Disease: Results of A Delphi Process by Ultrasound Working Group 160
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 160
SAT0315 Calcium Pyrophosphate Dihydrate Deposition Disease: A Proposal of New Ultrasonographic Criteria for CPP Identification in the Joints 160
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 160
Efficacy of extracorporeal shock wave treatment in calcaneal enthesophytosis. 157
AB0535 Effects of tocilizumab on bone density and metabolism in patients with active rheumatoid arthritis 157
SAT0510 Ultrasound versus Synovial Fluid Analysis for the Diagnosis of Calcium Pyrophosphate Dihydrate Deposition Disease: is IT Cppd? Ask Us! 157
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 156
Ultrasound in the diagnosis of calcium pyrophosphate dihydrate deposition disease. A systematic literature review and a meta-analysis 155
SAT0530 The Useful of us in Diagnosis of Carpal Tunnel Syndrome in Diabetics: a Proposal for New Reference Values 154
AB0969 Accuracy of blind intra-articular injections in patients with osteoarthritis of the knee. An ultrasonography controlled study 154
Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. 153
Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation 152
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 152
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 152
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 152
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 152
IL-6 blockade in the management of non-infectious uveitis 149
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 149
Biologic agents for rheumatoid arthritis: Can we hypothesize new strategies of treatment? 148
Extracorporeal shock wave therapy for chronic calcific tendinitis of the shoulder: single blind study 147
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes 146
null 145
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 144
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 143
Comment on: longitudinal examination with shoulder ultrasound in patients with polymyalgia rheumatica. 143
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 142
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 142
Heel fat pad involvement in rheumatoid arthritis and in spondyloarthropathies: an ultrasonographic study. 140
Tumour necrosis factor receptor-associated periodic syndrome(TRAPS): State of the art and future perspectives 139
Determinants of bone turnover markers in healthy premenopausal women 139
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature 138
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 138
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 137
Ultrasonography before and after surgery in carpal tunnel syndrome and relationship with clinical and electrophysiological findings. A new outcome predictor? 137
null 135
Biological treatments in Behçet's disease: beyond anti-TNF therapy 134
Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes 133
FRI0475 Radiologists against rheumatologists on technical aspects of shoulder ultrasound: from the disagreement to final consensus 133
null 133
Evidences for antinociceptive effect of 17-alpha-hydroxyprogesterone caproate in carpal tunnel syndrome 132
Prognostic bioindicators in severe COVID-19 patients 132
Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined 131
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art 131
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 131
null 131
Cytokine signatures in mucocutaneous and Ocular Behçet's disease 130
OP0122 Inter-Reader and Intra-Reader Reliability of The New Omeract Ultrasonographic Criteria for The Diagnosis of CPPD 130
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review 129
Ultrasound of enthesopathy in rheumatic diseases 128
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 128
Totale 16.596
Categoria #
all - tutte 110.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.137 720 260 413 879 356 551 533 771 560 551 189 354
2020/20215.719 306 499 236 546 375 826 236 798 491 503 400 503
2021/20224.486 384 533 307 347 261 177 195 202 273 461 473 873
2022/20235.472 363 431 680 723 438 1.079 253 450 526 156 220 153
2023/20245.357 211 161 488 294 263 1.310 1.599 206 49 140 175 461
2024/2025339 339 0 0 0 0 0 0 0 0 0 0 0
Totale 34.545